Investigations of an optimal inhaler technique with the use of urinary salbutamol excretion as a measure of relative bioavailability to the lung.

Eitemau Tebyg

• Determination of the relative bioavailability of salbutamol to the lung following inhalation.
  gan: Hindle, M, et al.
  Cyhoeddwyd: (1992)
• Relative bioavailability of salbutamol to the lung following inhalation using metered dose inhalation methods and spacer devices.
  gan: Hindle, M., et al.
  Cyhoeddwyd: (1994)
• Relative bioavailability of terbutaline to the lung following inhalation, using urinary excretion
  gan: Abdelrahim, Mohamed E, et al.
  Cyhoeddwyd: (2011)
• Relative bioavailability of sodium cromoglycate to the lung following inhalation, using urinary excretion
  gan: Aswania, O A, et al.
  Cyhoeddwyd: (1999)
• Relative bioavailability of salbutamol to the lung following inhalation via a novel dry powder inhaler and a standard metered dose inhaler
  gan: Hindle, M., et al.
  Cyhoeddwyd: (1997)